TransMedics Group, Inc.

NasdaqGM:TMDX Stok Raporu

Piyasa değeri: US$2.7b

TransMedics Group Yönetim

Yönetim kriter kontrolleri 4/4

TransMedics Group CEO'su Waleed Hassanein, Aug1998 tarihinde atandı, in görev süresi 26.25 yıldır. in toplam yıllık tazminatı $ 6.76M olup, şirket hissesi ve opsiyonları dahil olmak üzere 9.4% maaş ve 90.6% ikramiyelerden oluşmaktadır. şirketin hisselerinin 1.4% ine doğrudan sahiptir ve bu hisseler $ 37.77M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 7.5 yıl ve 11.3 yıldır.

Anahtar bilgiler

Waleed Hassanein

İcra Kurulu Başkanı

US$6.8m

Toplam tazminat

CEO maaş yüzdesi9.4%
CEO görev süresi26.3yrs
CEO sahipliği1.4%
Yönetim ortalama görev süresi7.5yrs
Yönetim Kurulu ortalama görev süresi11.3yrs

Son yönetim güncellemeleri

Recent updates

TransMedics: Overreaction To Temporary Headwinds (Rating Upgrade)

Nov 12

What You Can Learn From TransMedics Group, Inc.'s (NASDAQ:TMDX) P/S After Its 44% Share Price Crash

Oct 30
What You Can Learn From TransMedics Group, Inc.'s (NASDAQ:TMDX) P/S After Its 44% Share Price Crash

TransMedics: Mistakes Have Been Made, Here's My Updated Outlook

Oct 29

TransMedics' Organ Care: Critical Innovation With Lofty Expectations

Oct 23

TransMedics Group: This Could Be One Of The Biggest Moats In A Decade

Oct 16

Returns Are Gaining Momentum At TransMedics Group (NASDAQ:TMDX)

Sep 18
Returns Are Gaining Momentum At TransMedics Group (NASDAQ:TMDX)

TransMedics: Take Profits While The Valuation Is Sky High

Sep 18

TransMedics: Wide Moat Player At A Lower Valuation Than Peers

Sep 10

TransMedics Group, Inc.'s (NASDAQ:TMDX) P/S Is Still On The Mark Following 25% Share Price Bounce

Aug 28
TransMedics Group, Inc.'s (NASDAQ:TMDX) P/S Is Still On The Mark Following 25% Share Price Bounce

TransMedics: Heart And Lungs Will Drive The Next Leg Higher

Aug 19

Analysts Just Made A Meaningful Upgrade To Their TransMedics Group, Inc. (NASDAQ:TMDX) Forecasts

Aug 06
Analysts Just Made A Meaningful Upgrade To Their TransMedics Group, Inc. (NASDAQ:TMDX) Forecasts

TransMedics Group: Providing Long-Term Detailed Forecast And Upgrading To Buy

Aug 04

TransMedics Group, Inc. Just Recorded A 66% EPS Beat: Here's What Analysts Are Forecasting Next

Aug 02
TransMedics Group, Inc. Just Recorded A 66% EPS Beat: Here's What Analysts Are Forecasting Next

TransMedics Group Stock: Too Far, Too Fast

Jul 08

TransMedics: NOP, Logistics And Transport Are Key Growth Drivers But Stock Is Pricey

Jun 17

TransMedics Group (NASDAQ:TMDX) Might Have The Makings Of A Multi-Bagger

Jun 10
TransMedics Group (NASDAQ:TMDX) Might Have The Makings Of A Multi-Bagger

TransMedics: Transportation Supporting Growth

May 21

TransMedics Group: Looking At The Road Ahead After An Exceptional Q1 (Rating Downgrade)

May 06

TransMedics Group, Inc. (NASDAQ:TMDX) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Apr 24
TransMedics Group, Inc. (NASDAQ:TMDX) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

TransMedics Group: Founder Led Company With Solid Potential

Apr 19

Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

Apr 11
Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

TransMedics Group: Emerging Medical Device Market Leader With A Long Growth Runway

Mar 19

TransMedics Group: Huge Opportunity In Organ Transplants

Mar 12

TransMedics: A Very Expensive Growth Stock

Feb 07

With TransMedics Group, Inc. (NASDAQ:TMDX) It Looks Like You'll Get What You Pay For

Jan 23
With TransMedics Group, Inc. (NASDAQ:TMDX) It Looks Like You'll Get What You Pay For

Calculating The Fair Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

Jan 02
Calculating The Fair Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

Does TransMedics Group (NASDAQ:TMDX) Have A Healthy Balance Sheet?

Nov 05
Does TransMedics Group (NASDAQ:TMDX) Have A Healthy Balance Sheet?

This Just In: Analysts Are Boosting Their TransMedics Group, Inc. (NASDAQ:TMDX) Outlook for This Year

Aug 06
This Just In: Analysts Are Boosting Their TransMedics Group, Inc. (NASDAQ:TMDX) Outlook for This Year

TransMedics Group (NASDAQ:TMDX) Has Debt But No Earnings; Should You Worry?

Aug 02
TransMedics Group (NASDAQ:TMDX) Has Debt But No Earnings; Should You Worry?

TransMedics Group, Inc. (NASDAQ:TMDX) Not Lagging Industry On Growth Or Pricing

Jun 29
TransMedics Group, Inc. (NASDAQ:TMDX) Not Lagging Industry On Growth Or Pricing

Brokers Are Upgrading Their Views On TransMedics Group, Inc. (NASDAQ:TMDX) With These New Forecasts

May 06
Brokers Are Upgrading Their Views On TransMedics Group, Inc. (NASDAQ:TMDX) With These New Forecasts

Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

Apr 27
Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

Estimating The Intrinsic Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

Apr 09
Estimating The Intrinsic Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

CEO Tazminat Analizi

Waleed Hassanein'un ücretlendirmesi TransMedics Group'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

US$33m

Jun 30 2024n/an/a

US$3m

Mar 31 2024n/an/a

-US$10m

Dec 31 2023US$7mUS$634k

-US$25m

Sep 30 2023n/an/a

-US$36m

Jun 30 2023n/an/a

-US$18m

Mar 31 2023n/an/a

-US$28m

Dec 31 2022US$3mUS$575k

-US$36m

Sep 30 2022n/an/a

-US$42m

Jun 30 2022n/an/a

-US$48m

Mar 31 2022n/an/a

-US$47m

Dec 31 2021US$7mUS$535k

-US$44m

Sep 30 2021n/an/a

-US$38m

Jun 30 2021n/an/a

-US$30m

Mar 31 2021n/an/a

-US$28m

Dec 31 2020US$2mUS$534k

-US$29m

Sep 30 2020n/an/a

-US$32m

Jun 30 2020n/an/a

-US$35m

Mar 31 2020n/an/a

-US$36m

Dec 28 2019US$3mUS$449k

-US$34m

Sep 28 2019n/an/a

-US$32m

Jun 29 2019n/an/a

-US$29m

Mar 30 2019n/an/a

-US$26m

Dec 29 2018US$524kUS$384k

-US$24m

Sep 29 2018n/an/a

-US$21m

Jun 30 2018n/an/a

-US$20m

Mar 31 2018n/an/a

-US$20m

Dec 30 2017US$601kUS$351k

-US$21m

Tazminat ve Piyasa: Waleed 'ın toplam tazminatı ($USD 6.76M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 6.60M ).

Tazminat ve Kazançlar: Waleed 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Waleed Hassanein (56 yo)

26.3yrs

Görev süresi

US$6,758,070

Tazminat

Dr. Waleed H. Hassanein, M.D. is the Founder of Transmedics Group, Inc. and has been its President, Chief Executive Officer and Director since August 1998. He Founded TransMedics, Inc. in August 1998 and h...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Waleed Hassanein
Founder26.3yrsUS$6.76m1.4%
$ 37.8m
Stephen Gordon
CFO, Treasurer & Secretary9.7yrsUS$2.64m0.063%
$ 1.7m
Nicholas Corcoran
Senior Vice President of Supply Chain & Operations1.8yrsUS$2.52m0.0096%
$ 259.3k
Anil Ranganath
Senior VP1.3yrsUS$2.35m0.026%
$ 715.8k
Tamer Khayal
Chief Commercial Officer18.8yrsUS$2.63m0.062%
$ 1.7m
Miriam Provost
Vice President of Global Regulatory Affairs5.4yrsUS$813.47kVeri yok

7.5yrs

Ortalama Görev Süresi

56yo

Ortalama Yaş

Deneyimli Yönetim: TMDX 'un yönetim ekibi deneyimli ve deneyimlidir ( 7.5 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Waleed Hassanein
Founder26.3yrsUS$6.76m1.4%
$ 37.8m
Edwin Kania
Independent Director21.8yrsUS$220.28k0.91%
$ 24.5m
Merilee Raines
Independent Director3.8yrsUS$238.62k0.0036%
$ 95.9k
James Tobin
Independent Chairman13.8yrsUS$262.32k0.52%
$ 14.0m
Edward Zavala
Member of Advisory Boardno dataVeri yokVeri yok
Gayle Winters
Member of Advisory Boardno dataVeri yokVeri yok
Ryszard Smolenski
Member of Advisory Boardno dataVeri yokVeri yok
Bruce Rosengard
Member of Advisory Boardno dataVeri yokVeri yok
Scott D. Solomon
Member of Advisory Boardno dataVeri yokVeri yok
Robert Kormos
Member of Advisory Boardno dataVeri yokVeri yok
Edward Basile
Independent Director8.8yrsUS$232.26k0.0022%
$ 58.9k
Thomas Gunderson
Independent Director8.3yrsUS$237.74k0.0036%
$ 95.9k

11.3yrs

Ortalama Görev Süresi

70.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: TMDX 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 11.3 yıldır).